These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


654 related items for PubMed ID: 35469167

  • 21. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [Abstract] [Full Text] [Related]

  • 22. A diet high in α-linolenic acid and monounsaturated fatty acids attenuates hepatic steatosis and alters hepatic phospholipid fatty acid profile in diet-induced obese rats.
    Hanke D, Zahradka P, Mohankumar SK, Clark JL, Taylor CG.
    Prostaglandins Leukot Essent Fatty Acids; 2013 Feb; 89(6):391-401. PubMed ID: 24140006
    [Abstract] [Full Text] [Related]

  • 23. Non-Alcoholic Fatty Liver Disease.
    Engin A.
    Adv Exp Med Biol; 2017 Feb; 960():443-467. PubMed ID: 28585211
    [Abstract] [Full Text] [Related]

  • 24. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
    Park HS, Song JW, Park JH, Lim BK, Moon OS, Son HY, Lee JH, Gao B, Won YS, Kwon HJ.
    Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
    [Abstract] [Full Text] [Related]

  • 25. Diospyros kaki and Citrus unshiu Mixture Improves Disorders of Lipid Metabolism in Nonalcoholic Fatty Liver Disease.
    Shin MR, Shin SH, Roh SS.
    Can J Gastroenterol Hepatol; 2020 Sep; 2020():8812634. PubMed ID: 33425805
    [Abstract] [Full Text] [Related]

  • 26. Combined alcoholic and non-alcoholic steatohepatitis.
    Ntandja Wandji LC, Gnemmi V, Mathurin P, Louvet A.
    JHEP Rep; 2020 Jun; 2(3):100101. PubMed ID: 32514497
    [Abstract] [Full Text] [Related]

  • 27. Trans-10, cis-12 conjugated linoleic acid decreases de novo lipid synthesis in human adipocytes.
    Obsen T, Faergeman NJ, Chung S, Martinez K, Gobern S, Loreau O, Wabitsch M, Mandrup S, McIntosh M.
    J Nutr Biochem; 2012 Jun; 23(6):580-90. PubMed ID: 21775116
    [Abstract] [Full Text] [Related]

  • 28. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats.
    Liu L, Yang M, Lin X, Li Y, Liu C, Yang Y, Yamahara J, Wang J, Li Y.
    J Ethnopharmacol; 2013 Dec 12; 150(3):1045-52. PubMed ID: 24157375
    [Abstract] [Full Text] [Related]

  • 29. Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation.
    Li P, Zhang R, Wang M, Chen Y, Chen Z, Ke X, Zuo L, Wang J.
    Front Pharmacol; 2022 Dec 12; 13():917329. PubMed ID: 35847050
    [Abstract] [Full Text] [Related]

  • 30. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis.
    Shearn CT, Smathers RL, Jiang H, Orlicky DJ, Maclean KN, Petersen DR.
    J Nutr Biochem; 2013 Aug 12; 24(8):1436-45. PubMed ID: 23465594
    [Abstract] [Full Text] [Related]

  • 31. Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets.
    Bianco C, Casirati E, Malvestiti F, Valenti L.
    JHEP Rep; 2021 Jun 12; 3(3):100284. PubMed ID: 34027340
    [Abstract] [Full Text] [Related]

  • 32. Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor.
    Dong R, Yang X, Wang C, Liu K, Liu Z, Ma X, Sun H, Huo X, Fu T, Meng Q.
    Phytomedicine; 2019 Feb 12; 53():134-142. PubMed ID: 30668392
    [Abstract] [Full Text] [Related]

  • 33. Artemether Ameliorates Non-Alcoholic Steatohepatitis by Repressing Lipogenesis, Inflammation, and Fibrosis in Mice.
    Xu J, He X, Huang X, Zhang F, Ren X, Asakiya C, Li Y, Huang K.
    Front Pharmacol; 2022 Feb 12; 13():851342. PubMed ID: 35586049
    [Abstract] [Full Text] [Related]

  • 34. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J, Vijayakumar A, Ghoshal S, Marchand B, Yi S, Kornyeyev D, Zagorska A, Hollenback D, Walker K, Liu K, Pendem S, Newstrom D, Brockett R, Mikaelian I, Kusam S, Ramirez R, Lopez D, Li L, Fuchs BC, Breckenridge DG.
    J Hepatol; 2020 Oct 12; 73(4):896-905. PubMed ID: 32376414
    [Abstract] [Full Text] [Related]

  • 35. Hepatic lipid profile in mice fed a choline-deficient, low-methionine diet resembles human non-alcoholic fatty liver disease.
    Haberl EM, Pohl R, Rein-Fischboeck L, Höring M, Krautbauer S, Liebisch G, Buechler C.
    Lipids Health Dis; 2020 Dec 09; 19(1):250. PubMed ID: 33298075
    [Abstract] [Full Text] [Related]

  • 36. Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis.
    Bhattacharya D, Basta B, Mato JM, Craig A, Fernández-Ramos D, Lopitz-Otsoa F, Tsvirkun D, Hayardeny L, Chandar V, Schwartz RE, Villanueva A, Friedman SL.
    JHEP Rep; 2021 Jun 09; 3(3):100237. PubMed ID: 34151243
    [Abstract] [Full Text] [Related]

  • 37. A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice.
    Depner CM, Traber MG, Bobe G, Kensicki E, Bohren KM, Milne G, Jump DB.
    PLoS One; 2013 Jun 09; 8(12):e83756. PubMed ID: 24358308
    [Abstract] [Full Text] [Related]

  • 38. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios.
    Peter A, Cegan A, Wagner S, Lehmann R, Stefan N, Königsrainer A, Königsrainer I, Häring HU, Schleicher E.
    Clin Chem; 2009 Dec 09; 55(12):2113-20. PubMed ID: 19850634
    [Abstract] [Full Text] [Related]

  • 39. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
    Che L, Chi W, Qiao Y, Zhang J, Song X, Liu Y, Li L, Jia J, Pilo MG, Wang J, Cigliano A, Ma Z, Kuang W, Tang Z, Zhang Z, Shui G, Ribback S, Dombrowski F, Evert M, Pascale RM, Cossu C, Pes GM, Osborne TF, Calvisi DF, Chen X, Chen L.
    Gut; 2020 Jan 09; 69(1):177-186. PubMed ID: 30954949
    [Abstract] [Full Text] [Related]

  • 40. USP7 mediates pathological hepatic de novo lipogenesis through promoting stabilization and transcription of ZNF638.
    Ni W, Lin S, Bian S, Zheng W, Qu L, Fan Y, Lu C, Xiao M, Zhou P.
    Cell Death Dis; 2020 Oct 10; 11(10):843. PubMed ID: 33040080
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 33.